Your browser doesn't support javascript.
loading
COVID-19 Vaccination of Individuals with Down Syndrome-Data from the Trisomy 21 Research Society Survey on Safety, Efficacy, and Factors Associated with the Decision to Be Vaccinated.
Hüls, Anke; Feany, Patrick T; Zisman, Sophia Isabella; Costa, Alberto C S; Dierssen, Mara; Balogh, Robert; Bargagna, Stefania; Baumer, Nicole T; Brandão, Ana Claudia; Carfi, Angelo; Chicoine, Brian Allen; Ghosh, Sujay; Lakhanpaul, Monica; Levin, Johannes; Lunsky, Yona; Manso, Coral; Okun, Eitan; Real de Asua, Diego; Rebillat, Anne-Sophie; Rohrer, Tilman R; Sgandurra, Giuseppina; Valentini, Diletta; Sherman, Stephanie L; Strydom, Andre.
Afiliação
  • Hüls A; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.
  • Feany PT; Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.
  • Zisman SI; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.
  • Costa ACS; South London and Maudsley NHS Foundation Trust, London SE5 8AZ, UK.
  • Dierssen M; Department of Psychiatry, Case Western Reserve University, Cleveland, OH 44106, USA.
  • Balogh R; Department of Macromolecular Science and Engineering, Case Western Reserve University, Cleveland, OH 44106, USA.
  • Bargagna S; Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Universitat Pompeu Fabra, 08016 Barcelona, Spain.
  • Baumer NT; Universitat Pompeu Fabra (UPF), 08016 Barcelona, Spain.
  • Brandão AC; Centrode Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 08016 Barcelona, Spain.
  • Carfi A; Faculty of Health Sciences, Ontario Tech University, Oshawa, ON L1G 0C5, Canada.
  • Chicoine BA; Department of Developmental Neuroscience, IRCCS Fondazione Stella Maris, 56128 Calambrone, Italy.
  • Ghosh S; Department of Neurology, Division of Developmental Medicine, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Lakhanpaul M; Hospital Israelita Albert Einstein, Sao Paulo 01000-000, SP, Brazil.
  • Levin J; Policlinico Universitario Agostino Gemelli IRCCS, 00100 Rome, Italy.
  • Lunsky Y; Advocate Medical Group Adult Down Syndrome Center, Park Ridge, IL 60068, USA.
  • Manso C; Cytogenetics and Genomics Research Unit, Department of Zoology, University of Calcutta, Kolkata 700073, India.
  • Okun E; Department of Population Policy and Practice, UCL Great Ormond Street Institute of Child Health, University College, London WC1N 1EH, UK.
  • Real de Asua D; Community Paediatrics, Whittington Health NHS, London N19 5NF, UK.
  • Rebillat AS; Department of Neurology, Ludwig-Maximilians-Universität München, 80539 Munich, Germany.
  • Rohrer TR; German Center for Neurodegenerative Diseases, Site Munich, 53127 Munich, Germany.
  • Sgandurra G; Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany.
  • Valentini D; Azrieli Adult Neurodevelopmental Centre, CAMH, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A1, Canada.
  • Sherman SL; Down España, 28001 Madrid, Spain.
  • Strydom A; The Paul Feder Laboratory on Alzheimer's Disease Research, Bar Ilan University, Ramat Gan 5290002, Israel.
  • On Behalf Of The Trisomy Research Society Covid-Initiative; The Gonda Brain Research Center, Bar Ilan University, Ramat Gan 5290002, Israel.
Vaccines (Basel) ; 10(4)2022 Mar 29.
Article em En | MEDLINE | ID: mdl-35455279

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article